Toxicity management for patients receiving novel T-cell engaging therapies

DM Barrett, DT Teachey, SA Grupp - Current opinion in pediatrics, 2014 - journals.lww.com
DM Barrett, DT Teachey, SA Grupp
Current opinion in pediatrics, 2014journals.lww.com
Toxicity management for patients receiving novel T-cell enga... : Current Opinion in
Pediatrics Toxicity management for patients receiving novel T-cell engaging therapies :
Current Opinion in Pediatrics Log in or Register Subscribe to journalSubscribe Get new
issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation
Subscribe Register Login Articles & Issues Videos For Authors Journal Info Advanced
Search February 2014 - Volume 26 - Issue 1 Previous Article Next Article HEMATOLOGY …
Summary
Detailed studies of the T-cell activation produced by these novel therapies has led to more targeted approaches that have the potential to control toxicity while maintaining efficacy.
Lippincott Williams & Wilkins